MEOBF:OTCMKTS
Mesoblast Ltd
1,53 $
0,00%
(0,00) 1D
9 қаз., 10:32:50 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Mkt. cap
1,78 млрд
Avg. vol.
391,00
Volume
0,00
52-wk high
2,59 $
52-wk low
1,14 $
Beta
1,68
Shares outstanding
1,30 млрд
No. of employees
108
Mkt. cap
1,78 млрд
Avg. vol.
391,00
Volume
0,00
52-wk high
2,59 $
52-wk low
1,14 $
Beta
1,68
Shares outstanding
1,30 млрд
No. of employees
108
News stories
From web sources and news partners
TipRanks
·
2 сағат бұрын
Mesoblast Posts First Full-Year Ryoncil Revenue Surge and Files 2026 Annual Report
Stock Titan
·
3 сағат бұрын
From US$17.2M a year earlier, FY2026 revenue climbs at Mesoblast (MESO).
Kalkine Media
·
12 сағат бұрын
Which ASX Penny Stocks Are Worth Watching in October 2026, Including Mesoblast (ASX:MSB)?
TipRanks
·
1 күн бұрын
Mesoblast Files Updated Corporate Governance Statement and ASX Appendix 4G
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd